Vimarsana
Biggest News Aggregation in the World

Page 14 - Ryan Weispfenning News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ryan Weispfenning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ryan Weispfenning Today - Breaking & Trending Today

Medtronic PulseSelect PFA System demonstrates impressive results in landmark PULSED AF global IDE trial - Vimarsana News

Medtronic PulseSelect PFA System demonstrates impressive results in landmark PULSED AF global IDE trial

/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its PulseSelect™ Pulsed Field Ablation (PFA) System...

Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2023 - Vimarsana News

Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2023

/PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, March 2, 2023, approved the fiscal year 2023 fourth quarter cash dividend of $0....

Medtronic Executive Vice President and CFO Karen Parkhill to speak at Cowen healthcare conference - Vimarsana News

Medtronic Executive Vice President and CFO Karen Parkhill to speak at Cowen healthcare conference

/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual Cowen healthcare...

Medtronic plc (NYSE:MDT) Q3 2023 Earnings Call Transcript - Vimarsana News

Medtronic plc (NYSE:MDT) Q3 2023 Earnings Call Transcript

Ryan Weispfenning: Good morning. I am Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations. Welcome to Minnesota where signs of spring are in the air.

MiniMed™ 780G system demonstrates superiority over multiple daily injections with CGM for type 1 diabetes management at one-year in ADAPT study - Vimarsana News

MiniMed™ 780G system demonstrates superiority over multiple daily injections with CGM for type 1 diabetes management at one-year in ADAPT study

/PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced one-year data from the ADAPT study (n=82), the first...